Abstract
The neurochemical pathology of Alzheimer's disease (AD) has been consistently shown to involve cholinergic degeneration in the cerebral cortex. This together with evidence from experimental animal studies showing that cholinergic neurones play a role in learning and memory processes has formed the basis of the cholinergic hypothesis of Alzheimer's dementia and the major rationale for neurotransmitter replacement therapy of the disorder.
MeSH terms
-
Acetylcholine / metabolism
-
Acetylcholine / physiology
-
Aged
-
Alzheimer Disease / drug therapy
-
Alzheimer Disease / metabolism
-
Alzheimer Disease / physiopathology*
-
Cerebral Cortex / drug effects
-
Cerebral Cortex / metabolism
-
Cerebral Cortex / physiopathology
-
Cholinesterase Inhibitors / pharmacology
-
Cholinesterase Inhibitors / therapeutic use
-
Female
-
Humans
-
Male
-
Parasympathetic Nervous System / physiopathology*
-
Parasympathomimetics / pharmacology
-
Parasympathomimetics / therapeutic use*
-
Phosphatidylcholines / pharmacology
-
Phosphatidylcholines / therapeutic use
Substances
-
Cholinesterase Inhibitors
-
Parasympathomimetics
-
Phosphatidylcholines
-
Acetylcholine